文献速递流行病学与生物统计真实世界研究与卫生经济

专科姑息治疗服务对医院、临终关怀机构或社区环境中晚期不可治愈疾病成人生活质量的影响:系统综述与Meta分析

Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2017-07-04

该系统综述与Meta分析纳入12项随机对照试验(其中10项报告2454例随机化患者,72%患癌),评估专科姑息治疗对晚期疾病患者生活质量的影响。结果显示专科姑息治疗对生活质量有小幅获益(SMD 0.16,95%CI 0.01–0.31),在癌症患者中略大,早期接受者尤为明显;疼痛及其他次要结局结论不确定。

要点

  • 专科姑息治疗对晚期疾病患者生活质量有小幅获益。
  • 癌症患者及早期接受专科姑息治疗者获益可能更明显。
  • 疼痛及其他次要结局的结论不确定。

核心结论

  • 专科姑息治疗与生活质量小幅改善相关,对早期接受该治疗的癌症患者可能效果最明显。
  • 若早期提供并通过筛查识别需求未满足的患者,可能最为有效。

研究设计与样本

  • 系统综述与Meta分析,检索Medline、Embase、Cochrane对照试验中心注册库、PsycINFO及试验注册库至2016年7月。
  • 纳入在医院、临终关怀机构或社区环境中接受治疗的晚期疾病成人住院或门诊患者的随机对照试验。
  • 专科姑息治疗的最低要求包括多专业团队方式。
  • 由两名评价者独立筛选和提取数据,评估偏倚风险(Cochrane偏倚风险工具)和证据质量(GRADE工具)。
  • 共纳入12项发表研究(10项随机对照试验,2454例随机化患者,其中72%(n=1766)患癌)。

主要发现

  • 总体专科姑息治疗对生活质量有小幅获益:SMD 0.16(95%CI 0.01–0.31;QLQ-C30总体健康/生活质量4.1,0.3–8.2;n=1218,6项试验)。
  • 敏感性分析显示SMD为0.57(95%CI -0.02–1.15;总体健康/生活质量14.6,-0.5–29.4;n=1385,7项试验)。
  • 癌症患者效应略大:SMD 0.20(95%CI 0.01–0.38;总体健康/生活质量5.1,0.3–9.7;n=828,5项试验)。
  • 早期接受专科姑息治疗者效应尤为明显:SMD 0.33(95%CI 0.05–0.61;总体健康/生活质量8.5,1.3–15.6;n=388,2项试验)。
  • 疼痛及其他次要结局的结果不确定。

关键数值与推荐

  • 主要结局为生活质量,采用Hedges' g作为标准化均数差(SMD),Meta分析采用随机效应模型。
  • 生活质量分析的合并SMD被重新表达为欧洲癌症研究与治疗组织QLQ-C30总体健康/生活质量量表(第29和30条目)(0–100,高值=生活质量好,最小临床重要差异8.1)。
  • 无试验根据筛查识别的患者需求触发专科姑息治疗的整合。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 无试验根据筛查识别的患者需求触发专科姑息治疗的整合。
  • 部分方法学问题(如缺乏盲法)降低了证据强度。
  • 疼痛及其他次要结局的结果不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective To assess the effect of specialist palliative care on quality of life and additional outcomes relevant to patients in those with advanced illness.Design Systematic review with meta-analysis.Data sources Medline, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, and trial registers searched up to July 2016.Eligibility criteria for selecting studies Randomised controlled trials with adult inpatients or outpatients treated in hospital, hospice, or community settings with any advanced illness. Minimum requirements for specialist palliative care included the multiprofessional team approach. Two reviewers independently screened and extracted data, assessed the risk of bias (Cochrane risk of bias tool), and evaluated the quality of evidence (GRADE tool).Data synthesis Primary outcome was quality of life with Hedges' g as standardised mean difference (SMD) and random effects model in meta-analysis. In addition, the pooled SMDs of the analyses of quality of life were re-expressed on the global health/QoL scale (item 29 and 30, respectively) of the European Organization for Research and Treatment of Cancer QLQ-C30 (0-100, high values=good quality of life, minimal clinically important difference 8.1).Results Of 3967 publications, 12 were included (10 randomised controlled trials with 2454 patients randomised, of whom 72% (n=1766) had cancer). In no trial was integration of specialist palliative care triggered according to patients' needs as identified by screening. Overall, there was a small effect in favour of specialist palliative care (SMD 0.16, 95% confidence interval 0.01 to 0.31; QLQ-C30 global health/QoL 4.1, 0.3 to 8.2; n=1218, six trials). Sensitivity analysis showed an SMD of 0.57 (-0.02 to 1.15; global health/QoL 14.6, -0.5 to 29.4; n=1385, seven trials). The effect was marginally larger for patients with cancer (0.20, 0.01 to 0.38; global health/QoL 5.1, 0.3 to 9.7; n=828, five trials) and especially for those who received specialist palliative care early (0.33, 0.05 to 0.61, global health/QoL 8.5, 1.3 to 15.6; n=388, two trials). The results for pain and other secondary outcomes were inconclusive. Some methodological problems (such as lack of blinding) reduced the strength of the evidence.Conclusions Specialist palliative care was associated with a small effect on QoL and might have most pronounced effects for patients with cancer who received such care early. It could be most effective if it is provided early and if it identifies though screening those patients with unmet needs.Systematic review registration PROSPERO CRD42015020674.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Gaertner J, Siemens W, Meerpohl JJ, et al. Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis. BMJ. 2017. PMID: 28676557. doi:10.1136/bmj.j2925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。